Vivus Inc has announced that Actavis Plc plans to market a generic version of Qsymia (phentermine plus topiramate).Actavis has already...
The FDA has approved Qsymia (phentermine and topiramate extended-release) formerly Qnexa from Vivus Inc., as an addition to a reduced-calorie...
A new study concludes that weight loss resulting from treatment with Qsymia (phentermine and topiramate extended-release), from Vivus inc., led...